BRAF and colorectal carcinoma: The reason for the decreased frequency of MSI-H among patients with BRAF-mutated non-CRC GI malignancies is not certain, but prior work has demonstrated that non-V600E BRAF-mutated CRC exhibits lower rates of MSI-H [32].